SavedAdd your journal

Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2013 / Cilt: 22 - Sayı: 1

Periton diyalizi hastalarında periton membran transportu Beta-2 Mikroglobülinin Periton klirensini etkiler mi?

Does peritoneal membrane transport affect peritoneal Clearance of Beta 2 Microglobulin in Peritoneal Dialysis Patients?

Bülent TOKGÖZ
Oktay OYMAK
Cengiz UTAŞ
Mesut AKÇAKAYA
Feridun KAVUNCUOĞLU
Aydın ÜNAL
Pages
101–105
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Dialysate B2M level and peritoneal clearance of B2M were higher in the high transporter group than in the low transporter group (5.92 ± 2.62 mg/L vs. 3.42 ± 1.51 mg/L, p:

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Our aim in this study was to compare peritoneal clearance of beta 2-microglobulin (B2M) in peritoneal dialysis (PD) patients who had high and low membrane transport status.
📊
Key Findings & Data:Serum B2M levels and peritoneal clearance of B2M were compared between the two groups.
💡
Conclusion & Impact:Results: Dialysate B2M level and peritoneal clearance of B2M were higher in the high transporter group than in the low transporter group (5.92 ± 2.62 mg/L vs. 3.42 ± 1.51 mg/L, p:
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Our aim in this study was to compare peritoneal clearance of beta 2-microglobulin (B2M) in peritoneal dialysis (PD) patients who had high and low membrane transport status. MATERIAL and Methods: Forty-nine PD patients were included in this study. The patients were divided into two groups according to their peritoneal equilibration test (PET) results; high transport group and low transport group. Serum B2M levels and peritoneal clearance of B2M were compared between the two groups. Results: Dialysate B2M level and peritoneal clearance of B2M were higher in the high transporter group than in the low transporter group (5.92 ± 2.62 mg/L vs. 3.42 ± 1.51 mg/L, p:

Özet

AMAÇ: Bu çalışmada, yüksek ve düşük geçirgen membran transport özelliğine sahip periton diyalizi (PD) hastalarında beta 2-mikroglobülinin (B2M) periton klirenslerini karşılaştırmayı amaçladık. GEREÇ ve YÖNTEMLER: Kırk dokuz PD hastası çalışmaya alındı. Hastalar periton eşitleme testi (PET) sonuçlarına göre iki gruba ayrıldı; yüksek geçirgen grup ve düşük geçirgen grup. İki grup arasında serum B2M düzeyleri ve B2Mnin periton klirensleri karşılaştırıldı. Bulgular: Diyalizat B2M düzeyi ve B2Mnin periton klirensleri yüksek geçirgen grupta düşük geçirgen gruba kıyasla daha yüksekti (sırasıyla 5,92 ± 2,62 mg/Lye karşın 3,42 ± 1,51mg/L, p:

🔖

Cite This Article

TOKGÖZ, B., OYMAK, O., UTAŞ, C., AKÇAKAYA, M., KAVUNCUOĞLU, F., ÜNAL, A. (2022). Periton diyalizi hastalarında periton membran transportu Beta-2 Mikroglobülinin Periton klirensini etkiler mi?. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 22 - Sayı: 1, 101–105. https://ajindex.com/articles/655004

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, MaenoYamakawa T, Inaba M, Nishizawa Y: Serum beta2-microglobulin evel is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24: 571-577 Karlsson FA: Physical-chemical properties of beta 2-microglobulin. Immunochemistry 1974; 11: 111-114
  2. Orlando RA, Rader K, Authier F, Yamazaki H, Posner BI, Bergeron JJ, Farquhar MG: Megalin is an endocytic receptor for insulin. J Am Soc Nephrol 1998; 9: 1759-1766
  3. Lonneman G, Koch KM: Beta (2)-microglobulin amyloidosis: effects of ultrapure dialysate and dialyzer membrane. J Am Soc Nephrol 2002; 13(suppl1): S72-S77 Kazama JJ, Maruyama H, Gejyo F: Reduction of circulating beta2- microglobulin level for the treatment of dialysis related amyloidosis. Nephrol Dial Transplant 2001; 16 (Suppl 4): 31-35
  4. Niwa T, Sato M, Katsuzaki T, Tomoo T, Miyazaki T, Tatemichi N, Takei Y, Kondo T: Amyloid beta2-microglobulin is modified with N epsilon-(carboxymethyl) lysine in dialysis related amyloidosis. Kidney Int 1996; 50: 1303-1309
  5. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H: Involvement of beta2-microglobulin modified with advanced glycation and products in the pathogenesis of hemodialysis- associated amyloidosis. J Clin Invest 1994; 93: 521-528
  6. Assounga A, Canaud B, Flavier JL, Slingeneyer A, Robinet-Lévy M, Aznar R, Mion C: What does circulating beta2-microglobulin signify in uremic patients on maintenance dialysis? Nephrologie 1987; 8: 301-306
  7. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y: Superior dialytic clearance of beta2-microglobulin and P-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 2006; 70: 794-799
  8. Bolasco P, Altieri P, Andrulli S, Basile C, Di Filippo S, Feriani M, Pedrini L, Santoro A, Zoccali C, Sau G, Locatelli F: Convection versus diffusion in dialysis: An Italian prospective multicentre study. Nephrol Dial Transplant 2003; 18 Suppl 7:vii50-4; discussion vii59-62 Fry AC, Singh DK, Chandna SM, Farrington K: Relative importance of residual function and convection in determining beta2- microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 2007; 25: 295-302 Twardowski ZJ: Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7: 95-108 National Kidney Foundation: K/DOQI Clinical Practice Guidelines for peritoneal dialysis Adequacy: Update 2000. Am J Kidney Dis 2001; 37(suppl 1): S65-S136 Yamamoto